Gastrointestinal tract

Bifidobacterium longum – BL03 (DSM 16603)

Constipation • Intestinal transit • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence

Bifidobacterium longum – W11 (LMG P-21586)

Reduction of gastro-intestinal discomfort related to IBS • Rebalance of intestinal microbiota • Non-transmissible rifamycins resistance • Production of Exopolysaccharides • Hepatic encephalopathy

Bifidobacterium breve – BR03 (DSM 16604)

Constipation • Intestinal transit • Anti-inflammatory • Reduction of gastro-intestinal discomfort • Inhibition of pathogenic E. coli • Restoration of a better dietary ω-6/ω-3 balance • Conjugated linoleic acids (CLA) production…

Bifidobacterium animalis subsp. lactis – BS01 (LMG P-21384)

Constipation • Intestinal transit • Reduction of gastrointestinal discomfort • Leaky gut • Strengthening of natural defences and natural immunity • Antioxidant activity • Reduced glutathione (GSH) and superoxide dismutase…

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top